D.C. Circuit Refuses to Remedy Hospital Wage Data Errors by Medicare
Client Alert | 1 min read | 11.14.05
By Robert L. Roth
Despite finding that the Centers for Medicare & Medicaid Services (“CMS”) had arbitrarily and capriciously denied the Palisades General Hospital's wage data correction requests and that the denials caused the Hospital not to qualify for $4 million from a geographic reclassification, the Court of Appeals for the D.C. Circuit in an October decision refused to grant relief restoring the hospital to the position it would have achieved had CMS acted properly. Palisades General Hospital Inc. v. Leavitt, 426 F.3d 400 (D.C. Cir. 2005).
"[T]he district court had jurisdiction only to vacate the Secretary's decision rejecting the hospital's revised wage data and to remand for further action consistent with its opinion," Court of Appeals Judge Judith W. Rogers wrote. "It did not, as the hospital contends, have jurisdiction to order either reclassification based upon those adjusted wage data or an adjusted reimbursement payment that would reflect such a reclassification." CMS has made clear that, on a remand, it would not provide the relief sought by the Hospital. Accordingly, the D.C. Circuit's decision seems to have effectively precluded the relief that the Hospital was seeking.
In light of this decision, hospitals that believe a CMS wage data determination will prevent them from properly qualifying for geographic reclassification need to act expeditiously so that a district court will have the authority to grant necessary relief.
Crowell & Moring partner Robert Roth represented the Hospital in the litigation.
Insights
Client Alert | 5 min read | 08.21.26
FTC Proposes Enforcement Policy Statement on Personalized Pricing: What Businesses Need to Know
On August 19, 2026, the Federal Trade Commission (FTC) announced a proposed Enforcement Policy Statement on personalized pricing — the practice of companies using consumers’ personal data to set individualized prices, discounts, coupons, or other incentives. The proposed statement, which is open for public comment for 30 days following publication in the Federal Register, marks a major step up in the FTC’s focus on data-driven pricing strategies and puts businesses across industries on notice that undisclosed or inadequately disclosed personalized pricing will not be tolerated. Importantly, while the proposed statement is not a binding legal requirement and does not create new legal obligations, it serves as an enforcement warning that the FTC is prepared to use its existing enforcement authority under Section 5 of the FTC Act (Section 5) and is also a potential harbinger of rulemaking. Businesses that engage in — or are considering — personalized pricing should carefully assess their disclosure practices and data collection procedures against the standards articulated in this statement.
Client Alert | 7 min read | 08.19.26
CMS’s Final Rule Bans Federal Medicaid Funding for Youth Gender-Affirming Care
Client Alert | 2 min read | 08.19.26
